List of SBIR/STTR awards granted to EXHALIX, LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to EXHALIX, LLC in August, 2018 for $1,499,116.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HL121871-02A1 | Phase II | 1,499,116 | August 15, 2018 | |||||||
A SBIR Phase I contract was awarded to EXHALIX, LLC in September, 2021 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM144027-01 | Phase I | 300,000 | September 20, 2021 | |||||||
A SBIR Phase II contract was awarded to EXHALIX, LLC in August, 2022 for $500,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2SB1HL121871-04 | Phase II | 500,000 | August 15, 2022 | |||||||
A SBIR Phase I contract was awarded to EXHALIX, LLC in February, 2020 for $298,273.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL150884-01 | Phase I | 298,273 | February 17, 2020 | |||||||
A SBIR Phase I contract was awarded to EXHALIX, LLC in August, 2022 for $300,396.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG076027-01A1 | Phase I | 300,396 | August 15, 2022 | |||||||
A SBIR Phase I contract was awarded to EXHALIX, LLC in July, 2016 for $225,000.0 USD from the National Science Foundation. | SBIR | 1620855 | Phase I | 225,000 | July 1, 2016 | |||||||
A STTR Phase I contract was awarded to EXHALIX, LLC for $215,724.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41HL121871-01 | Phase I | 215,724 | ||||||||
A SBIR Phase II contract was awarded to EXHALIX, LLC in September, 2023 for $1,244,870.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM144027-02 | Phase II | 1,244,870 | September 1, 2023 |
